Overview

Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation

Status:
Unknown status
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Corneal disease is a leading cause of blindness in the world. A shortage of corneal donor tissue has prevented many patients from regaining vision. Additionally, refractive error such as myopia is a major cause of impaired visual function worldwide. Although refractive error is correctable by procedures that modify the refractive power of the cornea, these procedures often weaken corneal integrity and have risk of complications. This study aims to evaluate the safety and efficacy of corneal surface epithelium repair and regeneration in the treatment of corneal surface diseases and refractive error using autologous limbal stem cell transplantation.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Betamethasone
Betamethasone benzoate
Betamethasone sodium phosphate
Betamethasone Valerate
Betamethasone-17,21-dipropionate
Levofloxacin
Ofloxacin
Polystyrene sulfonic acid